Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Insomnia Severity Index (ISI): Psychometric properties and diagnostic performance in Romanian population
Larisa Cristina Ioana Tînc1, Ionuț Stelian Florean2, Văcăraș Vitalie3
1Doctoral School "Evidence-Based Assessment and Psychological Interventions", Babes-Bolyai University.
None:
Insomnia Severity Index (ISI) is one of the most widely used screening instruments for chronic insomnia, yet limitations in prior studies leave aspects of its psychometric properties incomplete. This study aimed to validate the ISI and investigate its screening utility in a clinical and nonclinical Romanian sample (N = 326; Mage = 25.84). Results indicate good internal consistency (αT1 = .84, αT2 = .86) and good test-rest reliability (r = .82). ISI significantly correlates with depression (r = .69), anxiety (r = .52), self-esteem (r = -.42), and quality of sleep (r = .75), supporting its concurrent and convergent validity. Regression analyses confirm its predictive validity, based on neurologists' (β = .39) and clinicians' (β = .43) diagnostic ratings of chronic insomnia. A cutoff score of 13 is optimal for a good balance between sensitivity (.79) and specificity (.68). Confirmatory factor analysis supports a two-factor model. Moreover, measurement invariance analyses show that ISI functions equivalently across the clinical and nonclinical groups. Overall, ISI scores provide reliable and valid information for screening chronic insomnia in patients with or without other psychiatric and/or medical conditions. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Self-Report Tests of Personality
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...

